RESUMEN

BACKGROUNDCytotoxic T lymphocyte antigen 4 (CTLA4) is essential for immune homeostasis. Genetic mutations causing haploinsufficiency (CTLA4h) lead to a phenotypically heterogenous, immune-mediated disease that can include neuroinflammation. The neurological manifestations of CTLA4h are poorly characterized.METHODSWe performed an observational natural history study of 50 patients with CTLA4h who were followed at the NIH. We analyzed clinical, radiological, immunological, and histopathological data.RESULTSEvidence for neuroinflammation was observed in 32% (n = 16 of 50) of patients in this cohort by magnetic resonance imaging (MRI) and/or by cerebrospinal fluid analysis. Clinical symptoms were commonly absent or mild in severity, with headaches as the leading complaint (n = 13 of 16). The most striking findings were relapsing, large, contrast-enhancing focal lesions in the brain and spinal cord observed on MRI. We detected inflammation in the cerebrospinal fluid and leptomeninges before the parenchyma. Brain biopsies of inflammatory lesions from 10 patients showed perivascular and intraparenchymal mixed cellular infiltrates with little accompanying demyelination or neuronal injury.CONCLUSIONSNeuroinflammation due to CTLA4h is mediated primarily by an infiltrative process with a distinct and striking dissociation between clinical symptoms and radiological findings in the majority of patients.FUNDINGNIAID, NIH, Division of Intramural Research, NINDS, NIH, Division of Intramural Research, and the National Multiple Sclerosis Society-American Brain Foundation.TRIAL REGISTRATIONClinicalTrials.gov NCT00001355.

Asunto(s)

Antígeno CTLA-4/deficiencia , Enfermedades del Sistema Nervioso Central/etiología , Haploinsuficiencia , Neuritis/etiología , Adolescente , Adulto , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Antígeno CTLA-4/genética , Antígeno CTLA-4/inmunología , Enfermedades del Sistema Nervioso Central/genética , Enfermedades del Sistema Nervioso Central/inmunología , Niño , Preescolar , Estudios de Cohortes , Femenino , Humanos , Estudios Longitudinales , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Neuritis/genética , Neuritis/inmunología , Neuroimagen , Neuroinmunomodulación , Médula Espinal/diagnóstico por imagen , Médula Espinal/patología , Adulto Joven

RESUMEN

BACKGROUND: Obesity is a low-grade inflammation condition that facilitates the development of numerous comorbidities and the dysregulation of brain homeostasis. Additionally, obesity also causes distinct behavioral alterations both in humans and rodents. Here, we investigated the effect of inducible genetic deletion of the cannabinoid type 1 receptor (CB1) in adipocytes (Ati-CB1-KO mice) on obesity-induced memory deficits, depressive-like behavior, neuroinflammation and adult neurogenesis. METHODS: Behavioral, mRNA expression and immunohistochemical studies were performed in Ati-CB1-KO mice and corresponding wild-type controls under standard and high-fat diet. RESULTS: Adipocyte-specific CB1 deletion reversed metabolic disturbances associated with an obese condition confirming previous studies. As compared to obese mice, the metabolic amelioration in Ati-CB1-KO mice was associated with an improvement of mood-related behavior and recognition memory, concomitantly with an increase in cell proliferation in metabolic relevant neurogenic niches in hippocampus and hypothalamus. In mutant mice, these changes were related to an increased neuronal maturation/survival in the hippocampus. Furthermore, CB1 deletion in adipocytes was sufficient to reduce obesity-induced inflammation, gliosis and apoptosis in a brain region-specific manner. CONCLUSIONS: Overall our data provide compelling evidence of the physiological relevance of the adipocyte-brain crosstalk where adipocyte-specific CB1 influences obesity-related cognitive deficits and depression-like behavior, concomitantly with brain remodeling, such as adult neurogenesis and neuroinflammation in the hippocampus and hypothalamus.

Asunto(s)

Adipocitos/metabolismo , Depresión/genética , Dieta Alta en Grasa/efectos adversos , Trastornos de la Memoria/etiología , Neuritis/genética , Neurogénesis/genética , Receptor Cannabinoide CB1/genética , Células Madre Adultas/fisiología , Animales , Conducta Animal/fisiología , Encéfalo/citología , Encéfalo/fisiología , Depresión/metabolismo , Eliminación de Gen , Masculino , Trastornos de la Memoria/genética , Trastornos de la Memoria/metabolismo , Trastornos de la Memoria/psicología , Ratones , Ratones Noqueados , Células-Madre Neurales/fisiología , Neuritis/metabolismo , Neuritis/patología , Especificidad de Órganos/genética , Receptor Cannabinoide CB1/deficiencia , Receptor Cannabinoide CB1/metabolismo

RESUMEN

BACKGROUND: α1,6-Fucosyltransferase-deficient (Fut8-/-) mice displayed increased locomotion and schizophrenia-like behaviors. Since neuroinflammation is a common pathological change in most brain diseases, this study was focused on investigating the effects of Fut8 in microglia and astrocytes. METHODS: Brain tissues were analyzed using immunohistochemical staining. Core fucosylation and protein expression were analyzed using lectin blot and western blot, respectively. Fut8-knockout (KO) cells were established by the CRISPR/Cas9 system. RESULTS: The number of Iba-1 positive cells and GFAP positive cells were significantly increased in both untreated and lipopolysaccharide stimulated inflammatory conditional Fut8-/- mice by comparison with both wild-type (Fut8+/+) and hetero (Fut8+/-) mice. Stimulation with pro-inflammatory factors, such as IFN-γ and IL-6, induced expression levels of fucosylation in primary microglia and astrocytes, as well as in glial cell lines. Cell motility and iNOS expression were easily induced by IFN-γ in Fut8-KO BV-2 cells compared with wild-type (WT) cells. In a similar manner, both Fut8-KO C6 cells and primary astrocytes treated with 2-fluoro-L-fucose, a specific inhibitor for fucosylation, showed a higher response to IL-6-stimulated phospho-STAT3 signaling, compared with WT cells. CONCLUSIONS: Core fucosylation negatively regulates the states of neuroinflammation by modulating the sensitivity of microglia and astrocytes to inflammatory mediators. The disorders of Fut8-/- mice are caused not only by neurons but also by glial cell dysfunction. GENERAL SIGNIFICANCE: Core fucose is a novel regulator for neuroinflammation in the central nervous system.

Asunto(s)

Fucosiltransferasas/genética , Mediadores de Inflamación/farmacología , Neuritis/genética , Neuroglía/efectos de los fármacos , Animales , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Células Cultivadas , Sistema Nervioso Central/efectos de los fármacos , Sistema Nervioso Central/inmunología , Sistema Nervioso Central/metabolismo , Sinergismo Farmacológico , Femenino , Fucosa/metabolismo , Fucosiltransferasas/metabolismo , Inflamación/genética , Inflamación/metabolismo , Inflamación/patología , Mediadores de Inflamación/metabolismo , Lipopolisacáridos , Masculino , Ratones , Ratones Endogámicos ICR , Ratones Noqueados , Neuritis/inducido químicamente , Neuritis/metabolismo , Neuroglía/inmunología , Neuroglía/metabolismo , Neuroinmunomodulación/efectos de los fármacos

RESUMEN

Distinguishing between hereditary and inflammatory neuropathy is usually straightforward on clinical grounds with the help of a family history. There are nevertheless cases where the distinction is less clear. The advent of molecular genetics has in the past several years aided confirmatory diagnosis for an increasing proportion of patients with genetic neuropathy. Various reports have described associations of Charcot-Marie-Tooth disease with a suspected or confirmed inflammatory neuropathy occasionally responding to immunotherapy. Possible predisposition to an inflammatory component was suggested in a subset of patients. Such reports have, however, been relatively few in number, suggesting the rarity of such associations and of such a predisposition if it exists. There have been a number of publications detailing clinical presentations suggestive of inflammatory neuropathy in patients with a known or later proven genetic aetiology, and subsequently felt to be part of the phenotype rather than representing an association. A number of genetically mediated multisystemic diseases with neuropathy have otherwise been reported as mimicking chronic inflammatory demyelinating polyneuropathy (CIDP). The most common example is that of familial amyloid polyneuropathy, of particular concern for the clinician when misdiagnosed as CIDP, in view of the therapeutic implications. We review the literature on reported associations, mimics and misdiagnoses of hereditary and inflammatory neuropathy and attempt to determine a practical approach to the problem in clinical practice using clinical features, electrophysiology, histopathology and targeted early genetic testing. The issue of attempting immunomodulatory therapy is discussed in view of the published literature.

Asunto(s)

Neuropatía Hereditaria Motora y Sensorial/diagnóstico , Neuropatía Hereditaria Motora y Sensorial/genética , Neuritis/diagnóstico , Neuritis/genética , Enfermedad de Charcot-Marie-Tooth/diagnóstico , Enfermedad de Charcot-Marie-Tooth/genética , Enfermedad de Charcot-Marie-Tooth/terapia , Errores Diagnósticos , Predisposición Genética a la Enfermedad , Pruebas Genéticas , Humanos , Enfermedades del Sistema Nervioso , Neuritis/inmunología , Fenotipo

RESUMEN

Peripheral neuroinflammation is characterized by hematogenous mononuclear leukocyte infiltration into peripheral nerves. Despite significant clinical knowledge, advancements in molecular biology and progress in developing specific drugs for inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis, there are currently no specific therapies that modulate pathogenic peripheral nerve inflammation. Modeling leukocyte trafficking at the blood-nerve barrier using a reliable human in vitro model and potential intravital microscopy techniques in representative animal models guided by human observational data should facilitate the targeted modulation of the complex inflammatory cascade needed to develop safe and efficacious therapeutics for immune-mediated neuropathies and chronic neuropathic pain.

Asunto(s)

Barrera Hematoencefálica/fisiopatología , Terapia Genética/métodos , Leucocitos/fisiología , Neuritis/terapia , Sistema Nervioso Periférico/patología , Animales , Humanos , Neuritis/genética , Sistema Nervioso Periférico/metabolismo

RESUMEN

Age is the principal nonmodifiable risk factor for stroke. Over the past 10 years, suitable models for stroke in aged rats have been established. At genetic and cellular level there are significant differences in behavioral, cytological and genomics responses to injury in old animals as compared with the young ones. Behaviorally, the aged rats have the capacity to recover after cortical infarcts albeit to a lower extent than the younger counterparts. Similarly, the increased vulnerability of the aged brain to stroke, together with a decreased interhemisphere synchrony after stroke, assessed by different experimental methods (MRI, fMRI, in vivo microscopy, EEG) leads to unfavorable recovery of physical and cognitive functions in aged people and may have a prognostic value for the recovery of stroke patients. Furthermore, in elderly, comorbidities like diabetes or arterial hypertension are associated with higher risk of stroke, increased mortality and disability, and poorer functional status and quality of life. Aging brain reacts strongly to ischemia-reperfusion injury with an early inflammatory response. The process of cellular senescence can be an important additional contributor to chronic post-stroke by creating a "primed" inflammatory environment in the brain. Overall, these pro-inflammatory reactions promote early scar formation associated with tissue fibrosis and reduce functional recovery. A better understanding of molecular factors and signaling pathways underlying the contribution of comorbidities to stroke-induced pathological sequelae, may be translated into successful treatment or prevention therapies for age-associated diseases which would improve lifespan and quality of life.

Asunto(s)

Envejecimiento , Neuritis/complicaciones , Accidente Cerebrovascular/complicaciones , Factores de Edad , Animales , Conducta Animal , Encéfalo/patología , Encéfalo/fisiopatología , Comorbilidad , Modelos Animales de Enfermedad , Humanos , Neuritis/genética , Neuritis/fisiopatología , Neuritis/psicología , Pronóstico , Recuperación de la Función , Factores de Riesgo , Accidente Cerebrovascular/genética , Accidente Cerebrovascular/patología , Accidente Cerebrovascular/fisiopatología , Accidente Cerebrovascular/psicología

RESUMEN

Sortilin is a member of the family of vacuolar protein sorting 10 protein domain receptors which has emerged as a co-receptor in cell death and neurodegeneration processes mediated by proneurotrophins. Here we tested the possibility that sortilin deficiency interferes with behavioral and neuropathological endpoints in a chronic Nerve Growth factor (NGF)-deprivation model of Alzheimer's disease (AD), the AD10 anti-NGF mouse. AD10 mice show cholinergic deficit, increased APP processing and tau hyper-phosphorylation, resulting in behavioral deficits in learning and memory paradigms assessed by novel object recognition and Morris water maze tests. Sort1(-/-) mice were crossed with AD10 anti-NGF mice and the neurodegenerative phenotype was studied. We found that the loss of sortilin partially protected AD10 anti-NGF mice from neurodegeneration. A protective effect was observed on non-spatial memory as assessed by novel object recognition, and histopathologically at the level of Aß and BFCNs, while the phosphotau increase was unaltered by knocking out sortilin. We suggest that sortilin might be involved in different aspects of neurodegeneration in a complex way, supporting the view that sortilin functions in the CNS are broader than being a co-receptor in proneurotrophin and neurotrophin signaling.

Asunto(s)

Proteínas Adaptadoras del Transporte Vesicular/fisiología , Enfermedad de Alzheimer/metabolismo , Factor de Crecimiento Nervioso/deficiencia , Proteínas Adaptadoras del Transporte Vesicular/genética , Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/patología , Precursor de Proteína beta-Amiloide/metabolismo , Animales , Colina/metabolismo , Neuronas Colinérgicas/metabolismo , Neuronas Colinérgicas/patología , Modelos Animales de Enfermedad , Trastornos de la Memoria/genética , Ratones , Ratones Mutantes , Neuritis/genética , Fosforilación , Modificación Traduccional de las Proteínas , Receptor trkA/biosíntesis , Transducción de Señal , Proteínas tau/metabolismo

RESUMEN

Toll-like receptor 4 (TLR4) has been demonstrated to play an important role during aseptic inflammation caused by nervous system diseases. The purpose of this study was to explore the underlying mechanism(s) regulating TLR4-mediated signaling and aseptic inflammatory responses following optic nerve injury in mice. We successfully generated an optic nerve crush model in mice in which the optic nerve upregulated TLR4 following injury. The protein expression levels of TLR4, Mac1, MyD88, NF-κB, IL-6 and TNF-α were significantly increased after optic nerve injury. Moreover, the expression levels of TLR4, NF-κB and TNF-α were robust at 2 weeks following injury; however, TRIF protein expression levels were low. In addition, we found that the mRNA transcript levels of MyD88 were higher than TRIF. IL-6 and TNF-α exhibited a statistically significant increase in their expression at 1 day, 1 week, 2 weeks and 3 weeks after optic nerve injury, compared with the normal and sham control groups (p-value <0.05). Therefore, the TLR4-mediated signaling pathway is activated following optic nerve injury in mice. We found that TLR4-MyD88-NF-κB signaling is the main signaling pathway activated in TLR4-mediated inflammation. Our results suggest this pathway may be a main pathway mediating inflammatory responses following optic nerve injury. This may provide insight into novel regenerative targets for the treatment of nerve injury.

Asunto(s)

Traumatismos del Nervio Óptico/metabolismo , Transducción de Señal/fisiología , Receptor Toll-Like 4/genética , Receptor Toll-Like 4/metabolismo , Animales , Modelos Animales de Enfermedad , Femenino , Interleucina-6/genética , Interleucina-6/metabolismo , Ratones , Ratones Endogámicos BALB C , Factor 88 de Diferenciación Mieloide/genética , Factor 88 de Diferenciación Mieloide/metabolismo , FN-kappa B/genética , FN-kappa B/metabolismo , Compresión Nerviosa , Regeneración Nerviosa/fisiología , Neuritis/genética , Neuritis/metabolismo , Neuritis/patología , Traumatismos del Nervio Óptico/genética , Traumatismos del Nervio Óptico/patología , ARN Mensajero/metabolismo , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo

RESUMEN

Targeting supraspinal pain control centers by gene transfer is known to induce sustained analgesia. In this study, we evaluated the effects of injecting a Herpes Simplex Virus type 1 vector which expresses enkephalin (HSV-ENK vector) in the lateralmost part of the caudal ventrolateral medulla (VLMlat), a pain control center that exerts mainly descending inhibitory effects on pain modulation. Overexpression of enkephalin at the VLMlat reduced the number of flinches during the early and delayed phases of the formalin test and decreased c-fos expression in the spinal cord. These antinociceptive effects were detected at 2 and 10days after injection of HSV-ENK in the VLMlat and were completely reversed by local administration of naloxone. Virally driven-enkephalin was expressed from transduced neurons located in the VLMlat and, at lower extent, in the rostral ventromedial medulla. Our results show that HSV-mediated expression of enkephalin in the VLMlat induced antinociceptive effects, likely due to an enhancement of the opioidergic input to the VLMlat which accounted for descending inhibition of the nociceptive transmission at the spinal cord. This study also demonstrates the value of HSV-1 derived vectors to manipulate, in a sustained and directed manner, pain modulatory pathways in the brain, which is important in the study of supraspinal pain control circuits.

Asunto(s)

Encefalinas/genética , Regulación Viral de la Expresión Génica/genética , Terapia Genética/métodos , Herpesvirus Humano 1/genética , Bulbo Raquídeo/virología , Neuralgia/terapia , Neuritis/terapia , Manejo del Dolor/métodos , Animales , Encefalinas/biosíntesis , Vectores Genéticos/genética , Vectores Genéticos/uso terapéutico , Inflamación/genética , Inflamación/terapia , Inflamación/virología , Masculino , Bulbo Raquídeo/citología , Neuralgia/genética , Neuralgia/virología , Neuritis/genética , Neuritis/virología , Ratas , Ratas Wistar

RESUMEN

Neuroinflammation is a common feature of many neurological disorders, and it is often accompanied by the release of proinflammatory cytokines and chemokines. Estradiol-17ß (E2) exhibits antiinflammatory properties, including the suppression of proinflammatory cytokines, in the central nervous system. However, the mechanisms employed by E2 and the role(s) of estrogen receptors (ERs) ERα and ERß are unclear. To investigate these mechanisms, we employed an in vivo lipopolysaccharide (LPS) model of systemic inflammation in ovariectomized (OVX) and OVX and E2-treated (OVX+E2) mice. Brain levels of proinflammatory cytokines (IL-1ß, IL-6, and IL-12p40) and chemokines (CCL2/MCP-1, CCL3/MIP-1α, CCL5/RANTES, and CXCL1/KC) were quantified in mice at 0 (sham), 3, 6, 12, and 24 h after infection using multiplex protein analysis. E2 treatment inhibited LPS-induced increases in all cytokines. In contrast, E2 treatment only suppressed CCL/RANTES chemokine concentrations. To determine whether ERα and ERß regulate brain cytokine and chemokine levels, parallel experiments were conducted using ERα knockout and ERß knockout mice. Our results revealed that both ERα and ERß regulated proinflammatory cytokine and chemokine production through E2-dependent and E2-independent mechanisms. To assess whether breakdown of the blood-brain barrier is an additional target of E2 against LPS-induced neuroinflammation, we measured Evan's blue extravasation and identified distinct roles for ERα and ERß. Taken together, these studies identify a dramatic cytokine- and chemokine-mediated neuroinflammatory response that is regulated through ERα- and ERß-mediated ligand-dependent and ligand-independent mechanisms.

Asunto(s)

Quimiocinas/biosíntesis , Citocinas/biosíntesis , Receptor alfa de Estrógeno/fisiología , Receptor beta de Estrógeno/fisiología , Mediadores de Inflamación/metabolismo , Neuritis/genética , Neuritis/metabolismo , Animales , Barrera Hematoencefálica/efectos de los fármacos , Barrera Hematoencefálica/metabolismo , Encéfalo/efectos de los fármacos , Encéfalo/inmunología , Encéfalo/metabolismo , Encéfalo/patología , Permeabilidad de la Membrana Celular/efectos de los fármacos , Permeabilidad de la Membrana Celular/genética , Estradiol/farmacología , Receptor alfa de Estrógeno/genética , Receptor alfa de Estrógeno/metabolismo , Receptor beta de Estrógeno/genética , Receptor beta de Estrógeno/metabolismo , Femenino , Lipopolisacáridos/farmacología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Neuritis/inducido químicamente , Neuritis/inmunología , Neuroinmunomodulación/efectos de los fármacos , Neuroinmunomodulación/genética

RESUMEN

Wallerian degeneration (WD) involves the fragmentation of axonal segments disconnected from their cell bodies, segmentation of the myelin sheath, and removal of debris by Schwann cells and immune cells. The removal and downregulation of myelin-associated inhibitors of axonal regeneration and synthesis of growth factors by these two cell types are critical responses to successful nerve repair. Here, we analyzed the transcriptome of the sciatic nerve of mice carrying the Wallerian degeneration slow (Wld(S)) mutant gene, a gene that confers axonal protection in the distal stump after injury, therefore causing significant delays in WD, neuroinflammation, and axonal regeneration. Of the thousands of genes analyzed by microarray, 719 transcripts were differentially expressed between Wld(S) and wild-type (wt) mice. Notably, the Nmnat1, a transcript contained within the sequence of the Wld(S) gene, was upregulated by five to eightfold in the sciatic nerve of naive Wld(S) mice compared with wt. The injured sciatic nerve of wt could be further distinguished from the one of Wld(S) mice by the preferential upregulation of genes involved in axonal processes and plasticity (Chl1, Epha5, Gadd45b, Jun, Nav2, Nptx1, Nrcam, Ntm, Sema4f), inflammation and immunity (Arg1, Lgals3, Megf10, Panx1), growth factors/cytokines and their receptors (Clcf1, Fgf5, Gdnf, Gfrα1, Il7r, Lif, Ngfr/p75(NTR), Shh), and cell adhesion and extracellular matrix (Adam8, Gpc1, Mmp9, Tnc). These results will help understand how the nervous and immune systems interact to modulate nerve repair, and identify the molecules that drive these responses.

Asunto(s)

Regeneración Nerviosa/genética , Proteínas del Tejido Nervioso/genética , Fenómenos Fisiológicos del Sistema Nervioso/genética , Neuritis/genética , Nervio Ciático/lesiones , Animales , Axones/fisiología , Axotomía , Adhesión Celular/fisiología , Análisis por Conglomerados , Citocinas/biosíntesis , ADN Complementario/biosíntesis , ADN Complementario/genética , Perfilación de la Expresión Génica , Hibridación in Situ , Ratones , Ratones Endogámicos C57BL , Factores de Crecimiento Nervioso/biosíntesis , Fenómenos Fisiológicos del Sistema Nervioso/inmunología , Neuritis/inmunología , Análisis de Secuencia por Matrices de Oligonucleótidos , ARN/biosíntesis , ARN/aislamiento & purificación

RESUMEN

As functional recovery following peripheral nerve injury is dependent upon successful repair and regeneration, treatments that enhance different regenerative events may be advantageous. Using a rat facial nerve crush axotomy model, our lab has previously investigated the effects of a combinatorial treatment strategy, consisting of electrical stimulation (ES) of the proximal nerve stump and testosterone propionate (TP) administration. Results indicated that the two treatments differentially enhance facial nerve regenerative properties, whereby ES reduced the delay before sprout formation, TP accelerated the overall regeneration rate, and the combinatorial treatment had additive effects. To delineate the molecular mechanisms underlying such treatments, the present study investigated the effects of ES and TP on expression of specific regeneration-associated genes. Following a right facial nerve crush at the stylomastoid foramen, gonadectomized adult male rats were administered only ES, only TP, a combination of both, or left untreated. Real time RT-PCR analysis was used to assess fold changes in mRNA levels in the facial motor nucleus at 0 h, 6 h, 1 d, 2 d, 7 d, and 21 d post-axotomy. The candidate genes analyzed included two tubulin isoforms (alpha(1)-tubulin and beta(II)-tubulin), 43-kiloDalton growth-associated protein (GAP-43), brain derived neurotrophic factor (BDNF), pituitary adenylate cyclase-activating peptide (PACAP), and neuritin (candidate plasticity-related gene 15). The two treatments have differential effects on gene expression, with ES leading to early but transient upregulation and TP producing late but steady increases in mRNA levels. In comparison to individual treatments, the combinatorial treatment strategy has the most enhanced effects on the transcriptional program activated following injury.

Asunto(s)

Andrógenos/uso terapéutico , Estimulación Eléctrica/métodos , Enfermedades del Nervio Facial/terapia , Regulación de la Expresión Génica/efectos de los fármacos , Regeneración Nerviosa/efectos de los fármacos , Propionato de Testosterona/uso terapéutico , Análisis de Varianza , Animales , Axotomía/métodos , Factor Neurotrófico Derivado del Encéfalo/genética , Factor Neurotrófico Derivado del Encéfalo/metabolismo , Modelos Animales de Enfermedad , Proteína GAP-43/genética , Proteína GAP-43/metabolismo , Masculino , Regeneración Nerviosa/fisiología , Neuritis/genética , Neuritis/metabolismo , Orquiectomía/métodos , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/genética , Polipéptido Hipofisario Activador de la Adenilato-Ciclasa/metabolismo , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Factores de Tiempo , Tubulina (Proteína)/genética , Tubulina (Proteína)/metabolismo

RESUMEN

Autoinflammatory syndromes include an expanding list of conditions characterized by unprovoked recurrent attacks of systemic inflammation with lack of auto-antibodies or autoreactive T cells. Many of these syndromes are genetic diseases with a Mendelian inheritance. Neurological manifestations may be one of the major clinical features and, in some cases, the presenting symptom of these syndromes. The purpose of this review is to increase the recognition among neurologists of the Mendelian-inherited autoinflammatory syndromes by highlighting the neurological manifestations in the context of other symptoms that should lead physicians to suspect these syndromes. Most important for neurologists are the cryopyrin-associated periodic syndromes that include familial cold autoinflammatory syndrome, Muckle-Wells syndrome and neonatal-onset multisystem inflammatory disease (called chronic infantile neurological cutaneous and articular syndrome in Europe). We also review other syndromes with less common neurological involvement, including familial Mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, and hyperimmunoglobulinemia D syndrome. Because these syndromes are often treatable and irreversible damage is prevented if they are treated early, it is important to recognize the features that may result in these syndromes presenting to a neurologist, especially in early childhood.

Asunto(s)

Enfermedades Genéticas Congénitas , Enfermedades del Sistema Inmune , Neuritis , Niño , Enfermedades Genéticas Congénitas/diagnóstico , Enfermedades Genéticas Congénitas/genética , Enfermedades Genéticas Congénitas/terapia , Humanos , Enfermedades del Sistema Inmune/diagnóstico , Enfermedades del Sistema Inmune/genética , Enfermedades del Sistema Inmune/terapia , Neuritis/diagnóstico , Neuritis/genética , Neuritis/terapia

RESUMEN

The non-obese diabetic (NOD) mouse strain is prone to developing various autoimmune syndromes including type I diabetes mellitus (T1DM), sialadenitis, thyroiditis and pancreatitis. Although the genetic basis of T1DM has been extensively analyzed, genetic factors that modify the other autoimmune phenotypes are largely unknown. We have recently reported that NOD mice with anti-diabetogenic MHC haplotype (H-2(b)) and programmed cell death 1 (PD-1) deficiency (NOD.H2(b)-Pdcd1(-/-) mice) are protected from T1DM but develop various tissue-specific autoimmune diseases including peripheral neuropathy due to autoimmune neuritis, sialadenitis and gastritis. In the present study, we generated [(C57BL/6 x NOD.H2(b))(F1) x NOD-H2(b)](BC1)-Pdcd1(-/-) mice to screen non-MHC quantitative trait loci (QTLs) that modify autoimmune phenotypes other than T1DM. We identified seven QTLs for peripheral neuropathy and neuritis, one QTL for insulitis, four QTLs for gastritis, two QTLs for sialadenitis and seven QTLs for vasculitis throughout the genome and designated them as Annp loci for autoimmunity due to polymorphisms of non-MHC genes in NOD mice and PD-1 deficiency. Annp1, 5, 6 and 7 overlapped with reported loci for T1DM (Idd3, 9, 15 and 2, respectively), suggesting that these loci modify not only T1DM but also other autoimmune phenotypes. NOD allele was promotive at 9 of 14 Annp loci, while NOD allele was protective at the other loci. Half of Annp loci associated with a single phenotype, while the other seven loci associated with more than two phenotypes. These results indicate that NOD genetic background harbors various QTLs that modify autoimmune phenotypes either by organ-specific or by organ-non-specific manner.

Asunto(s)

Autoinmunidad/genética , Predisposición Genética a la Enfermedad , Enfermedades del Sistema Nervioso Periférico/genética , Sitios de Carácter Cuantitativo , Animales , Antígenos de Superficie/genética , Antígenos de Superficie/inmunología , Proteínas Reguladoras de la Apoptosis/genética , Proteínas Reguladoras de la Apoptosis/inmunología , Autoinmunidad/inmunología , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/inmunología , Modelos Animales de Enfermedad , Gastritis/genética , Gastritis/inmunología , Gastritis/patología , Ratones , Ratones Endogámicos NOD , Ratones Noqueados , Neuritis/genética , Neuritis/inmunología , Neuritis/patología , Pancreatitis/genética , Pancreatitis/inmunología , Pancreatitis/patología , Enfermedades del Sistema Nervioso Periférico/patología , Receptor de Muerte Celular Programada 1 , Sialadenitis/genética , Sialadenitis/inmunología , Sialadenitis/patología , Vasculitis/genética , Vasculitis/inmunología , Vasculitis/patología

RESUMEN

After the Chernobyl nuclear accident, behavioural disorders and central nervous system diseases were frequently observed in populations living in the areas contaminated by (137)Cs. Until now, these neurological disturbances were not elucidated, but the presence of a neuro-inflammatory response could be one explanation. Rats were exposed for 3 months to drinking water contaminated with (137)Cs at a dose of 400Bqkg(-1), which is similar to that ingested by the population living in contaminated areas in the former USSR countries. Pro-inflammatory and anti-inflammatory cytokine genes were assessed by real-time PCR in the frontal cortex and the hippocampus. At this level of exposure, gene expression of TNF-alpha and IL-6 increased in the hippocampus and gene expression of IL-10 increased in the frontal cortex. Concentration of TNF-alpha, measured by ELISA assays, was also increased in the hippocampus. The central NO-ergic pathway was also studied: iNOS gene expression and cNOS activity were significantly increased in the hippocampus. In conclusion, this study showed for the first time that sub-chronic exposure with post-accidental doses of (137)Cs leads to molecular modifications of pro- and anti-inflammatory cytokines and NO-ergic pathway in the brain. This neuro-inflammatory response could contribute to the electrophysiological and biochemical alterations observed after chronic exposure to (137)Cs.

Asunto(s)

Radioisótopos de Cesio/toxicidad , Citocinas/metabolismo , Lóbulo Frontal/efectos de la radiación , Expresión Génica/efectos de la radiación , Hipocampo/efectos de la radiación , Neuritis/etiología , Animales , Accidente Nuclear de Chernóbil , Citocinas/genética , Inducción Enzimática , Ensayo de Inmunoadsorción Enzimática , Lóbulo Frontal/enzimología , Lóbulo Frontal/metabolismo , Hipocampo/enzimología , Hipocampo/metabolismo , Interleucina-10/metabolismo , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Interleucina-8/metabolismo , Masculino , Neuritis/genética , Neuritis/metabolismo , Óxido Nítrico Sintasa de Tipo II/biosíntesis , Óxido Nítrico Sintasa de Tipo II/genética , Óxido Nítrico Sintasa de Tipo III , Reacción en Cadena de la Polimerasa , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Factor de Crecimiento Transformador beta/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Regulación hacia Arriba

RESUMEN

Nucleoside analog-associated sensory neuropathy (NRTI-SN) attributed to stavudine, didanosine, or zalcitabine (the dNRTIs) and distal sensory polyneuropathy (DSP) attributed to HIV are clinically indistinguishable. As inflammatory cytokines are involved in DSP, we addressed a role for inflammation in NRTI-SN by determining the alleles of immune-related genes carried by patients with and without NRTI-SN. Demographic details associated with risk of various neuropathies were included in the analysis. Alleles of 14 polymorphisms in 10 genes were determined in Australian HIV patients with definite NRTI-SN (symptom onset <6 months after first dNRTI exposure, n = 16), NRTI-SN-resistant patients (no neuropathy despite >6 months on dNRTIs, n = 20), patients with late onset NRTI-SN (neuropathy onset after >6 months of dNRTIs, n = 19), and HIV-negative controls. Carriage of TNFA-1031*2 was highest in NRTI-SN patients, suggesting potentiation of NRTI-SN. Carriage of IL12B (3' UTR)*2 was higher in NRTI-SN-resistant patients than controls or NRTI-SN patients, suggesting a protective role. BAT1 (intron 10)*2 was more common in NRTI-SN than resistant patients, but neither group differed from controls. This marks the conserved HLA-A1, B8, DR3 haplotype. Of the demographic details considered, increasing height was associated with NRTI-SN risk. A model including cytokine genotype and height predicted NRTI-SN status (p < 0.0001, R(2) = 0.54). Late onset NRTI-SN patients clustered genetically with NRTI-SN-resistant patients, so these patients may be genetically "protected." In addition to patient height, cytokine genotype influenced NRTI-SN risk following dNRTI exposure, suggesting inflammation contributes to NRTI-SN.

Asunto(s)

Fármacos Anti-VIH/efectos adversos , Citocinas/genética , Predisposición Genética a la Enfermedad , Infecciones por VIH/complicaciones , Neuritis/genética , Trastornos Somatosensoriales/genética , Adulto , Australia , Estatura , Frecuencia de los Genes , Infecciones por VIH/inmunología , Haplotipos , Humanos , Persona de Mediana Edad , Modelos Estadísticos , Polimorfismo Genético

RESUMEN

Microglia, monocytes, and peripheral macrophages share a common origin and many characteristics, but what distinguishes them from each other at the level of gene expression remains largely unknown. In this study, we compared the transcriptional profiles of freshly purified microglia, monocytes, and spleen macrophages using Affymetrix Mouse Genome arrays to identify genes predominantly expressed by microglia. Among tens of thousands of genes assayed, 127 potential candidates were found, including nine newly discovered genes encoding plasma membrane and extracellular proteins. In the brain, the latter were selectively expressed by microglia, as revealed by in situ hybridization. Three of them were confirmed to be exclusively (MSR2) or predominantly (GPR12, GPR34) expressed in the brain compared to the other tissues examined. Furthermore, all of these genes were upregulated in activated microglia after treatment with the demyelinating toxin cuprizone, suggesting that they play roles in neuroinflammation. In conclusion, this study reports the identification of new selective markers for microglia, which should prove useful not only to identify and isolate these cells, but also to better understand their distinctive properties.

Asunto(s)

Biomarcadores , Microglía/inmunología , Neuritis/genética , Neuritis/inmunología , Análisis de Secuencia por Matrices de Oligonucleótidos , Animales , Encéfalo/citología , Encéfalo/inmunología , Quelantes/toxicidad , Cuprizona/toxicidad , Enfermedades Desmielinizantes/inducido químicamente , Enfermedades Desmielinizantes/genética , Enfermedades Desmielinizantes/inmunología , Modelos Animales de Enfermedad , Expresión Génica/efectos de los fármacos , Expresión Génica/inmunología , Hibridación in Situ , Masculino , Ratones , Ratones Endogámicos C57BL , Microglía/efectos de los fármacos , Neuritis/inducido químicamente , ARN Mensajero/análisis , Bazo/citología , Bazo/inmunología , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/inmunología

RESUMEN

Direct sequencing of the human cyclooxygenase-2 gene promoter revealed a common single nucleotide substitution, cyclooxygenase-2-765G-->C, in 24.5% of the populations analyzed. This change introduced a 20 base pair polypyrimidine/polypurine element and a partial recognition feature for RXRalpha, the 9-cis retinoic acid receptor, into the polymorphic promoter. Cyclooxygenase-2-765G-->C constructs, when transfected into human neural cells, exhibited a 1.4-fold higher level of basal expression, while the proinflammatory factors interleukin-1beta and 9-cis retinoic acid synergistically induced polymorphic promoter activity 2.4-fold over wild type. These results suggest that under specific conditions of cellular stress, a common variation in cyclooxygenase-2 promoter structure may enhance cyclooxygenase-2 transcription, and this may contribute to the proliferation of an inflammatory response in brain cells.

Asunto(s)

Encefalopatías/fisiopatología , Neuronas/fisiología , Polimorfismo de Nucleótido Simple , Prostaglandina-Endoperóxido Sintasas/genética , Secuencia de Bases , Encefalopatías/genética , Encefalopatías/inmunología , Células Cultivadas , Ciclooxigenasa 2 , Regulación Enzimológica de la Expresión Génica , Humanos , Proteínas de la Membrana , Datos de Secuencia Molecular , Neuritis/genética , Neuritis/inmunología , Neuritis/fisiopatología , Neuronas/citología , Regiones Promotoras Genéticas/genética , Transfección

Asunto(s)

Antirreumáticos/uso terapéutico , Artritis/tratamiento farmacológico , Proteínas Portadoras/genética , Dermatitis/tratamiento farmacológico , Neuritis/tratamiento farmacológico , Sialoglicoproteínas/uso terapéutico , Artritis/genética , Dermatitis/genética , Femenino , Humanos , Recién Nacido , Proteína Antagonista del Receptor de Interleucina 1 , Masculino , Mutación , Proteína con Dominio Pirina 3 de la Familia NLR , Neuritis/genética , Síndrome

RESUMEN

Opioid receptors (OR) and their mRNA are present in the central and peripheral nervous system of mammals. In this review we examine the behavioral effects of opioids and the expression of their receptors during peripheral inflammation in two experimental models: the rat paw and the mouse intestine. Inflammation increased the antinociceptive (paw) and the inhibitory effects of opioids in the gut (transit, permeability and plasma extravasation) by interaction with OR located at peripheral sites. Based on agonist efficacy, micro > delta >> kappa-OR mediate the antinociceptive and antitransit effects of opioids during inflammation. Intestinal permeability is modulated by delta = micro >> kappa-OR, while kappa > delta >> micro-OR are involved in the inhibition of plasma extravasation. Intestinal inflammation increased the transcription of micro and delta-OR (but not kappa) genes in the gut, thus explaining the enhanced antitransit and antisecretory effects of micro and delta-OR agonists; however, the increased inhibitory effects of kappa-OR agonists on plasma extravasation could result from post-transcriptional regulation of the receptor. Similarly, the increased expression of peripheral micro-OR observed in the rat paw during inflammation, occurs at post-transcriptional levels and is related to an increased axonal transport from the dorsal root ganglia to peripheral terminals. The sites and mechanisms implicated in the increased transcription of micro and delta-OR during intestinal inflammation are under investigation.

Asunto(s)

Neuritis/metabolismo , Receptores Opioides/metabolismo , Analgésicos/farmacología , Animales , Tránsito Gastrointestinal/efectos de los fármacos , Regulación de la Expresión Génica , Humanos , Mucosa Intestinal/metabolismo , Intestinos/efectos de los fármacos , Intestinos/inervación , Modelos Animales , Neuritis/genética , Permeabilidad/efectos de los fármacos , ARN Mensajero/metabolismo , Receptores Opioides/efectos de los fármacos , Receptores Opioides/genética